BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,956 | -24.8% | 1,225 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $55,811 | +12.3% | 1,225 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $49,686 | -52.6% | 1,225 | -40.4% | 0.00% | 0.0% |
| Q4 2022 | $104,743 | -5.6% | 2,055 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $111,000 | -15.9% | 2,055 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $132,000 | -45.0% | 2,055 | -33.6% | 0.00% | 0.0% |
| Q1 2022 | $240,000 | -25.0% | 3,095 | -17.0% | 0.00% | -33.3% |
| Q4 2021 | $320,000 | +6.7% | 3,730 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $300,000 | -22.3% | 3,730 | -22.2% | 0.00% | -25.0% |
| Q2 2021 | $386,000 | +293.9% | 4,793 | +291.3% | 0.00% | +300.0% |
| Q4 2020 | $98,000 | -1.0% | 1,225 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $99,000 | -5.7% | 1,225 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $105,000 | +6.1% | 1,225 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $99,000 | -7.5% | 1,225 | -3.9% | 0.00% | +100.0% |
| Q4 2019 | $107,000 | 0.0% | 1,275 | +4.1% | 0.00% | -50.0% |
| Q3 2019 | $107,000 | +7.0% | 1,225 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $100,000 | -2.0% | 1,225 | -2.6% | 0.00% | -50.0% |
| Q1 2019 | $102,000 | +22.9% | 1,258 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $83,000 | -28.4% | 1,258 | -16.1% | 0.00% | 0.0% |
| Q3 2018 | $116,000 | +4.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $111,000 | +13.3% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $98,000 | -10.9% | 1,500 | -11.8% | 0.00% | 0.0% |
| Q4 2017 | $110,000 | -3.5% | 1,700 | -6.1% | 0.00% | 0.0% |
| Q3 2017 | $114,000 | +10.7% | 1,811 | +6.5% | 0.00% | 0.0% |
| Q2 2017 | $103,000 | +17.0% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $88,000 | +31.3% | 1,700 | +13.3% | 0.00% | +100.0% |
| Q4 2016 | $67,000 | -5.6% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $71,000 | -7.8% | 1,500 | -12.4% | 0.00% | 0.0% |
| Q2 2016 | $77,000 | +24.2% | 1,713 | +14.2% | 0.00% | +100.0% |
| Q1 2016 | $62,000 | +8.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $57,000 | -90.4% | 1,500 | -82.4% | 0.00% | -93.3% |
| Q3 2015 | $596,000 | 0.0% | 8,525 | 0.0% | 0.02% | 0.0% |
| Q2 2015 | $596,000 | -11.4% | 8,525 | -13.2% | 0.02% | -11.8% |
| Q1 2015 | $673,000 | -54.0% | 9,825 | -50.8% | 0.02% | -10.5% |
| Q4 2014 | $1,462,000 | +494.3% | 19,950 | +482.5% | 0.02% | +171.4% |
| Q3 2014 | $246,000 | -0.8% | 3,425 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $248,000 | +55.0% | 3,425 | +57.3% | 0.01% | +75.0% |
| Q1 2014 | $160,000 | +6.0% | 2,177 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $151,000 | +51.0% | 2,177 | +42.8% | 0.00% | +33.3% |
| Q3 2013 | $100,000 | -5.7% | 1,525 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $106,000 | – | 1,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |